₂₁Gregg W Stone

Key Opinion Leader In [Gregg W Stone is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₉Immunoglobulin Fab Fragments | ₁₁Treatment Outcome | ₁₉Stents | ₂₀Angioplasty, Transluminal, Percutaneous Coronary | ₂₈Coronary Angiography | ₂₉Platelet Glycoprotein GPIIb-IIIa Complex | ₃₁Platelet Aggregation Inhibitors | ₃₃Sex Factors | ₃₄Coronary Disease | ₃₈Tyrosine | ₄₄Myocardial Infarction | ₄₅Registries | ₆₁Logistic Models | ₆₇Coronary Restenosis | ₇₅Blood Vessel Prosthesis Implantation | ₇₅Antibodies, Monoclonal | ₇₆Prospective Studies | ₈₃Aged | ₁₀₁Follow-Up Studies | ₁₀₆Predictive Value of Tests | ₁₁₇Coronary Artery Disease | ₁₃₁Randomized Controlled Trials as Topic | ₁₈₁Survival Analysis | ₁₉₃Female | ₂₀₃Survival Rate | ₂₃₆Male | ₂₄₂Middle Aged | ₂₇₂Time Factors | ₅₂₀Prognosis | ₅₅₂Risk Factors | ₆₆₁United States | ₇₁₂Humans

Keywords (32) [keywords assigned to Gregg W Stone articles by PubMed, the leading number and the color conveys importance]

₂₀Humans | ₁₈Male | ₁₈Female | ₁₅Aged | ₁₄Middle Aged | ₁₃Treatment Outcome | ₁₀Stents | ₈Angioplasty, Transluminal, Percutaneous Coronary | ₇Myocardial Infarction | ₆Coronary Angiography | ₆Coronary Disease | ₆Prospective Studies | ₅Follow-Up Studies | ₄Immunoglobulin Fab Fragments | ₄United States | ₄Platelet Aggregation Inhibitors | ₄Antibodies, Monoclonal | ₄Time Factors | ₄Platelet Glycoprotein GPIIb-IIIa Complex | ₄Risk Factors | ₃Coronary Artery Disease | ₃Survival Analysis | ₃Survival Rate | ₃Predictive Value of Tests | ₃Sex Factors | ₃Prognosis | ₃Coronary Restenosis | ₃Registries | ₃Randomized Controlled Trials as Topic | ₃Logistic Models | ₃Blood Vessel Prosthesis Implantation | ₃Tyrosine

Other [context-specific ads]

Gregg W Stone Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Gregg W Stone might be a good expert witness on these terms]

₃₄patients | ₂₆coronary | ₁₉myocardial | ₁₉clinical | ₁₆stent | ₁₆outcomes | ₁₅infarction | ₁₄proximal | ₁₄distal | ₁₃percutaneous | ₁₃angioplasty | ₁₁abciximab | ₁₁stenting | ₉restenosis | ₉tirofiban | ₉intervention | ₉months | ₈adverse | ₈events | ₈survival | ₈balloon | ₇results | ₇angiographic | ₇compared | ₇vs | ₇right | ₆outcome | ₆use | ₆delivery | ₆may | ₆primary | ₆undergoing
₁₅myocardial infarction | ₁₁percutaneous coronary | ₈acute myocardial | ₆coronary intervention | ₆primary angioplasty | ₆iib iiia | ₅coronary artery | ₅clinical outcome | ₅nir sox | ₅patients proximal | ₄proximal right | ₄adverse events | ₄target-vessel revascularisation | ₄sox stent | ₄balloon counterpulsation | ₄patients undergoing | ₄saphenous vein | ₄occlusion aspiration | ₄balloon occlusion | ₄glycoprotein iib | ₄aspiration system | ₄iiia inhibitors | ₃stent implantation | ₃benchmark registry | ₃proximal lad | ₃clinical restenosis | ₃myocardial perfusion | ₃protection distal | ₃procedural success | ₃infarction target-vessel | ₃death myocardial | ₃circumflex coronary
₈acute myocardial infarction | ₆percutaneous coronary intervention | ₄nir sox stent | ₄occlusion aspiration system | ₄balloon occlusion aspiration | ₄glycoprotein iib iiia | ₄iib iiia inhibitors | ₃infarction target-vessel revascularisation | ₃death myocardial infarction | ₃myocardial infarction target-vessel | ₂graft stenting technical | ₂counterpulsation catheters based | ₂stenting saphenous vein | ₂transmyocardial laser revascularization | ₂chronic total occlusions | ₂may help design | ₂normalized myocardial perfusion | ₂catheters based patients | ₂technical clinical correlates | ₂saphenous vein grafts | ₂prospective multicenter randomized | ₂protection saphenous vein | ₂filter protection saphenous | ₂size intra-aortic balloon | ₂trial percutaneous transmyocardial | ₂complications outcomes cardiac | ₂patients proximal right | ₂distal embolization stenting | ₂perfusion successful angioplasty | ₂myocardial perfusion successful | ₂percutaneous transmyocardial laser | ₂proximal right circumflex

Authoratory™
•home •community •tutorial •authors •keywords •search •top ranked •login	Update 2008, Q3 Live! Excel CSV XML print ₂₁Gregg W Stone 2002 \| 2003 >> Summary Social Network Interests Funding Articles Comments All Key Opinion Leader In [Gregg W Stone is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors] ₉Immunoglobulin Fab Fragments \| ₁₁Treatment Outcome \| ₁₉Stents \| ₂₀Angioplasty, Transluminal, Percutaneous Coronary \| ₂₈Coronary Angiography \| ₂₉Platelet Glycoprotein GPIIb-IIIa Complex \| ₃₁Platelet Aggregation Inhibitors \| ₃₃Sex Factors \| ₃₄Coronary Disease \| ₃₈Tyrosine \| ₄₄Myocardial Infarction \| ₄₅Registries \| ₆₁Logistic Models \| ₆₇Coronary Restenosis \| ₇₅Blood Vessel Prosthesis Implantation \| ₇₅Antibodies, Monoclonal \| ₇₆Prospective Studies \| ₈₃Aged \| ₁₀₁Follow-Up Studies \| ₁₀₆Predictive Value of Tests \| ₁₁₇Coronary Artery Disease \| ₁₃₁Randomized Controlled Trials as Topic \| ₁₈₁Survival Analysis \| ₁₉₃Female \| ₂₀₃Survival Rate \| ₂₃₆Male \| ₂₄₂Middle Aged \| ₂₇₂Time Factors \| ₅₂₀Prognosis \| ₅₅₂Risk Factors \| ₆₆₁United States \| ₇₁₂Humans Keywords (32) [keywords assigned to Gregg W Stone articles by PubMed, the leading number and the color conveys importance] ₂₀Humans \| ₁₈Male \| ₁₈Female \| ₁₅Aged \| ₁₄Middle Aged \| ₁₃Treatment Outcome \| ₁₀Stents \| ₈Angioplasty, Transluminal, Percutaneous Coronary \| ₇Myocardial Infarction \| ₆Coronary Angiography \| ₆Coronary Disease \| ₆Prospective Studies \| ₅Follow-Up Studies \| ₄Immunoglobulin Fab Fragments \| ₄United States \| ₄Platelet Aggregation Inhibitors \| ₄Antibodies, Monoclonal \| ₄Time Factors \| ₄Platelet Glycoprotein GPIIb-IIIa Complex \| ₄Risk Factors \| ₃Coronary Artery Disease \| ₃Survival Analysis \| ₃Survival Rate \| ₃Predictive Value of Tests \| ₃Sex Factors \| ₃Prognosis \| ₃Coronary Restenosis \| ₃Registries \| ₃Randomized Controlled Trials as Topic \| ₃Logistic Models \| ₃Blood Vessel Prosthesis Implantation \| ₃Tyrosine Other [context-specific ads] Gregg W Stone Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Gregg W Stone might be a good expert witness on these terms] ₃₄patients \| ₂₆coronary \| ₁₉myocardial \| ₁₉clinical \| ₁₆stent \| ₁₆outcomes \| ₁₅infarction \| ₁₄proximal \| ₁₄distal \| ₁₃percutaneous \| ₁₃angioplasty \| ₁₁abciximab \| ₁₁stenting \| ₉restenosis \| ₉tirofiban \| ₉intervention \| ₉months \| ₈adverse \| ₈events \| ₈survival \| ₈balloon \| ₇results \| ₇angiographic \| ₇compared \| ₇vs \| ₇right \| ₆outcome \| ₆use \| ₆delivery \| ₆may \| ₆primary \| ₆undergoing ₁₅myocardial infarction \| ₁₁percutaneous coronary \| ₈acute myocardial \| ₆coronary intervention \| ₆primary angioplasty \| ₆iib iiia \| ₅coronary artery \| ₅clinical outcome \| ₅nir sox \| ₅patients proximal \| ₄proximal right \| ₄adverse events \| ₄target-vessel revascularisation \| ₄sox stent \| ₄balloon counterpulsation \| ₄patients undergoing \| ₄saphenous vein \| ₄occlusion aspiration \| ₄balloon occlusion \| ₄glycoprotein iib \| ₄aspiration system \| ₄iiia inhibitors \| ₃stent implantation \| ₃benchmark registry \| ₃proximal lad \| ₃clinical restenosis \| ₃myocardial perfusion \| ₃protection distal \| ₃procedural success \| ₃infarction target-vessel \| ₃death myocardial \| ₃circumflex coronary ₈acute myocardial infarction \| ₆percutaneous coronary intervention \| ₄nir sox stent \| ₄occlusion aspiration system \| ₄balloon occlusion aspiration \| ₄glycoprotein iib iiia \| ₄iib iiia inhibitors \| ₃infarction target-vessel revascularisation \| ₃death myocardial infarction \| ₃myocardial infarction target-vessel \| ₂graft stenting technical \| ₂counterpulsation catheters based \| ₂stenting saphenous vein \| ₂transmyocardial laser revascularization \| ₂chronic total occlusions \| ₂may help design \| ₂normalized myocardial perfusion \| ₂catheters based patients \| ₂technical clinical correlates \| ₂saphenous vein grafts \| ₂prospective multicenter randomized \| ₂protection saphenous vein \| ₂filter protection saphenous \| ₂size intra-aortic balloon \| ₂trial percutaneous transmyocardial \| ₂complications outcomes cardiac \| ₂patients proximal right \| ₂distal embolization stenting \| ₂perfusion successful angioplasty \| ₂myocardial perfusion successful \| ₂percutaneous transmyocardial laser \| ₂proximal right circumflex

	The content of this page was generated automatically by a computer program. Copyright © 2006-2009 Authoratory.com \| All rights reserved \| Terms of use \| Privacy policy

21Gregg W Stone

Key Opinion Leader In [Gregg W Stone is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

Keywords (32) [keywords assigned to Gregg W Stone articles by PubMed, the leading number and the color conveys importance]

Other [context-specific ads]

Gregg W Stone Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Gregg W Stone might be a good expert witness on these terms]

₂₁Gregg W Stone